Discover the latest press releases from Crohn's & Colitis Foundation with the Atlanta Business Chronicle's BizSpotlight ...
A man from Cardiff who spent a year in hospital with an incurable bowel disease is now running his own business and embarking ...
Mariana Tata experienced a few subtle, common symptoms of colon cancer and got them checked out. She was diagnosed at stage 4 ...
Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ...
Explaining what PPIs are, the NHS says: "PPIs are a type of medicine which reduces the amount of acid your stomach makes.
Mirador Therapeutics, Inc. (Mirador), a clinical-stage precision medicine company developing next-generation therapies for ...
GlobalData on MSN
MRM Health receives FDA clearance for STARFISH-UC Phase IIb trial
MRM Health has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) ...
French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly's radar after ...
Shares in Nasdaq-listed Abivax soared in pre-market trading on Monday after reports emerged that pharma giant Eli Lilly was ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Zacks Investment Research on MSN
AbbVie down 3% in a month: Why holding the stock still makes sense
AbbVie ABBV stock has declined 3.2% in a month. Shares of this large drugmaker dipped recently after it denied takeover talks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results